Why the study?
Does immunosuppressive therapy improve outcomes in patients with virus-negative inflammatory cardiomyopathy?
Does immunosuppressive therapy improve outcomes in patients with virus-negative inflammatory cardiomyopathy?
Immunosuppressive therapy is efficacious in treating virus-negative inflammatory cardiomyopathy, although a small subset of patients may not respond.
No takes yet. Share an insight, caveat, or question.
Supports immunosuppression as standard in virus-negative inflammatory cardiomyopathy; confirms RCT efficacy while highlighting 12% non-response for further study.
Frustaci et al. (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: